IDYAIDEAYA Biosciences, Inc.
$36.12+40% 1Y
$36.12
$25.6752 weeks$42.48
The financials
IDEAYA Biosciences, Inc. by the numbers
IDEAYA Biosciences, Inc. (IDYA) reported revenue of $8.9M in Q2 2026 (quarter ended Jun 30, 2026). That came with net loss of $112M. For the full year FY2025, revenue was $219M (+3024% year on year) and net income −$114M. The next results filing is expected around Nov 3, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $8.9M | n/a | n/a |
| Operating income | −$122M | −$89M | n/a |
| Net income | −$112M | −$77M | n/a |
| Diluted EPS | −$1.22 | −$0.88 | n/a |
On our screens:Most shorted stocks